Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Wangpaichitr M, Wu C, Li YY, Nguyen DJM, Kandemir H, Shah S, Chen S, Feun LG, Prince JS, Kuo MT, Savaraj N.
Wangpaichitr M, et al. Among authors: prince js.
Oncotarget. 2017 Jul 25;8(30):49275-49292. doi: 10.18632/oncotarget.17568.
Oncotarget. 2017.
PMID: 28525376
Free PMC article.